RNRoohangiz Nashibi

Roohangiz Nashibi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Roohangiz Nashibi has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Elevated miRNA Expression and IL-6 Levels in COVID-19 Patients: Correlations and Implications for Inflammatory Response

    by Niloofar Neisi, Zahra Abolfath Beigi, Mehdi Parsanahad, Roya Pirmoradi, Roohangize Nashibi

    Background: The role of microRNAs (miRNAs) in viral diseases is well established. Due to the COVID-19 pandemic, this study analyzed the expression levels of miR200b-3p, miR34b-5p, miR203a-3p, and Let7g-5p in the blood samples of COVID-19 patients, along with the expression level of interleukin-6 (IL-6) as a biomarker. Objectives: The purpose of this study is to investigate the correlation between the expression levels of IL-6 and the mentioned miRNAs. Methods: The study included 60 COVID-19 patients confirmed by an infectious disease specialist and positive real-time PCR tests, hospitalized at Razi Hospital, Ahvaz. The control group consisted of thirty healthy people. COVID-19 disease was verified using oro-nasopharyngeal swab samples, and PBMC samples from patients were used to check the expression level of IL-6. Plasma samples were analyzed for the expression levels of miR200b-3p, miR34b-5p, miR203a-3p, and Let7g-5p. Results: All examined expression factors were markedly elevated in COVID-19 patients in comparison to the control group. Specifically, miR200b-3p (P < 0.00), Let7g-5p (P < 0.003), and miR203a-3p (P < 0.00) exhibited significantly higher levels in the infected group. MiR34b-5p (P < 0.02) also showed an increase, albeit to a lesser extent. Additionally, IL-6 expression was substantially higher in hospitalized patients. Positive correlations, though not statistically significant, were observed between miR200b-5p, miR203a-3p, miR34b-5p, and IL-6 expression. Conversely, a non-significant negative correlation was noted between Let7g and IL-6 in COVID-19 patients. Conclusions: This study establishes a relationship between the elevated expression of specific miRNAs (miR200b-3p, miR34b-5p, miR203a-3p, and Let7g-5p) and IL-6 in COVID-19 patients. The significant upregulation of these miRNAs, alongside increased IL-6 levels, underscores their potential role as biomarkers for COVID-19. These findings suggest that miRNA and IL-6 expression profiles could be instrumental in the diagnosis and management of COVID-19, providing new avenues for therapeutic interventions and improving patient outcomes.


  • Prevalence of SARS-CoV-2 in Patients with Severe Pneumonia in Khuzestan Province, Iran

    by Farhad Abolnezhadian, Manoochehr Makvandi, Seyed Mohammad Alavi, Azarakhsh Azaran, Shahram Jalilian, Mohammad Rashno, Gholam Abbas Kaydani, Maniya Arshadi, Seyed Mehdi Hosseinizadeh, Hatam Boostani, et al.

    The emergence of a highly pathogenic virus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) accounts for severe pneumonia throughout the world. More than 7 million world population have been infected with SARS-CoV-2, and the number of deaths is increasing every day. This study aimed to evaluate the frequency of SARS-CoV-2 in hospitalized patients with acute respiratory infection (ARI). During an outbreak of the SARS-CoV-2, the nasopharyngeal and oropharyngeal swabs were collected from 909 hospitalized patients with severe pneumonia, including 517 (56.9%) males and 392 (43.1%) females. All the collected samples were from different cities of Khuzestan province from 19 February to- 27 March 2020. The RNA was extracted from samples and subjected to real-time polymerase chain reaction (PCR) tests for the detection of the SARS-CoV-2. Simultaneously, the computerized tomography (CT) scan was tested for the presence of ground-glass opacity in the lung among the patients. Of the total number of 909 specimens, 328 (36.08%) cases, including 185 (20.35%) females and 143 (15.73%) males, were positive for the SARS-CoV-2 while, 581 (63.9%) cases, including 374 (41.14%) males and 207 (22.77%) were negative for the SARS-CoV-2 by real-time PCR (p=0.001).Four hundred sixteen (45.76%) cases were positive for ground-glass opacity in the lung by CT scan, while 328/909 (36.08%) trials proved positive for SARS-CoV-2 by the real-time PCR (p=0.003). In this study, 36.08% of patients were positive for SARS-CoV-2. Although the results of positive cases by CT scan showed higher than real-time PCR, screening the SARS-CoV-2 with a real-time PCR method is the first line of choice.